Design, Development and Characterization of Curcumin loaded Albumin Nanoparticles for the Treatment of Parkinson’s Disease

Authors

  • Shailja Choudhary Department of Pharmaceutics, Amity institute of Pharmacy, Noida-201301, Uttar Pradesh, India
  • Mayuri Jain Department of Pharmaceutics, Amity institute of Pharmacy, Noida-201301, Uttar Pradesh, India
  • Mojahidul Islam Department of Pharmaceutical Chemistry, School of Pharmacy, Sharda University, Greater Noida-201310, Uttar Pradesh, India

Abstract

Curcumin being component of Curcuma longa is a natural polyphenol. Observing on a chemical level, curcumin is a natural polyphenol which is denominated (1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene3,5-dione) which is usually extracted through the rhizomes of Curcuma longa. Structurally, it is composed of a trio of chemical identities on a molecular level: dual aromatic ring system. The objective of the research was to design, development and characterization of herbal drug loaded albumin nanoparticles to cure parkinson’s disease for improving and increasing the therapeutic efficacy and also reducing the frequency of dose. The optimized formulations were obtained after applying the design of experiment which was Box Behnken method where three independent variables; polymer concentration, stirring time, crosslinker concentration were selected.  Curcumin nanoparticles loaded with albumin were formulated by ph coacervation method in which ethanol was used as desolvating agent along with a cross linking agent (Glutaraldehyde) and albumin as the polymer. The particle size and polydispersity index of curcumin loaded albumin nanoparticles was measured via dynamic light scattering technique. Drug release research conducted using in vitro method over the duration of 24 hours. Ex vivo drug release study of the albumin nanoparticles was performed using nasal membrane of goat. It has been shown that in case of hydrophilic matrices, swelling of polymer occurs followed by release of drug by diffusion which was best explained by Korsmeyer- peppas equation, which indicates drug release through diffusion which occurs by swelling of polymer matrix and remained constant throughout the release of drug in body. By virtue of particle size, the designed nanoparticles effortlessly goes into the nasal mucosa.

Keywords:

Albumin nanoparticles, curcumin nanoparticles, anti-parkinson drug.

DOI

https://doi.org/10.25004/IJPSDR.2020.120107

References

Antiparkinsonian Drugs. In: KD Tripathi, Essentials of Medical Pharmacology, 7th Edition. Jaypee Brothers Medical Publishers (P) Ltd. New Delhi 2015. 425-434.

Rewar S. A systematic review on Parkinson's disease (PD). Indian Journal of Research in Pharmacy and Biotechnology. 2015 Mar 1; 3(2):176.

Lecht S, Haroutiunian S, Hoffman A, Lazarovici P. Rasagiline–a novel MAO B inhibitor in Parkinson’s disease therapy. Therapeutics and clinical risk management. 2007 Jun;3(3):467.

Rang HP, Dale MM, Ritter JM, Flower RJ. Neurodegenerative diseases In: Rang and Dales, Pharmacology, 6th Edition. Churchill Living Stone Elsevier New Delhi. 2007;4(35):517-522.

Aminoff M.J. Pharmacologic Management of Parkinsonism & Other Movement Disorders. In: Lange, Basic and Clinical Pharmacology, 11th edition. Tata McGraw Hill Edu.Pvt. Ltd. 2009;28(2):469-485.

Camargo LEA de, Brustolin Ludwig D, Tominaga TT, Carletto B, Favero GM, Mainardes RM, et al. Bovine serum albumin nanoparticles improve the antitumour activity of curcumin in a murine melanoma model. Journal of Microencapsulation [Internet]. Informa UK Limited; 2018 Jul 4;35(5):467–474.

Proctor, DF. The upper airways. I. nasal physiology and defense of the lungs, Am. Rev. Respir. Dis. 1977;115(1):97-129.

Chandrakantsing V P, Abhijeet D K, Veena S B, Sanjay J S. Intranasal Delivery of Nano Neurotherapeutics: A Meta Opinion. Glob J Nano. 2017;1(3):555-565.

Abbott NJ, Romero IA. Transporting therapeutics across the blood brain barrier. Mol Med Today. 1996;2:106–113.

Sharma D, Sharma RK, Sharma N, Gabrani R, Sharma SK, Ali J, Dang S. Nose-to-brain delivery of PLGA-diazepam nanoparticles. AAPS PharmSciTech. 2015 Oct 1;16(5):1108-1121.

Dhuria SV, Hanson LR, Frey WH. Intranasal delivery to the central nervous system: mechanism and experimental consideration. J Pharm Sci. 2010;99(4):1654–1673

Thadakapally R, Aafreen A, Aukunuru J, Habibuddin M, Jogala S. Preparation and Characterization of PEG-albumin-curcumin Nanoparticles Intended to Treat Breast Cancer. Indian J Pharm Sci. 2016;78(1):65–72.

Mittal D, Md S, Hasan Q, Fazil M, Ali A, Baboota S, et al. Brain targeted nanoparticulate drug delivery system of rasagiline via intranasal route. Drug Delivery; 2014 Apr 30;23(1):130–139.

Gulati N, Nagaich U, Saraf SA. International Delivery of Chitosan Nanoparticles for Migraine Therapy. Sci Pharm. 2013;81(4):843-854.

Basu S, Bandyopadhyay AK. Development and characterization of mucoadhesive in situ nasal gel of midazolam prepared with ficus carica mucilage. AAPS PharmSciTech. 2010;11(3):1223-1231.

Barcia E, Boeva L, García-García L, Slowing K, Fernández-Carballido A, Casanova Y, Negro S. Nanotechnology-based drug delivery of ropinirole for Parkinson’s disease. Drug delivery. 2017 Jan 1;24(1):1112-1123.

Yu K, Wang Y, Wan T, Zhai Y, Cao S, Ruan W, Wu C, Xu Y. Tacrolimus nanoparticles based on chitosan combined with nicotinamide: enhancing percutaneous delivery and treatment efficacy for atopic dermatitis and reducing dose. International journal of nanomedicine. 2018;13(1):129-142

Sonvico F, Clementino A, But tini F, Colombo G, Pescina S, Stanisçuaski Guterres S, Raffin Pohlmann A, Nicoli S. Surfacemodified nanocarriers for nose-to-brain delivery: from bioadhesion to targeting. Pharmaceutics. 2018 Mar;10(1):34.

Leelapornpisid P, Leesawat P, Natakarnkitkul S, Rattanapanadda P. Application of chitosan for preparation of arbutin nanoparticles as skin whitening. Journal of Metals, Materials and Minerals. 2010;20(3):101-105.

Published

30-01-2020
Statistics
Abstract Display: 511
PDF Downloads: 409
Dimension Badge

How to Cite

“Design, Development and Characterization of Curcumin Loaded Albumin Nanoparticles for the Treatment of Parkinson’s Disease”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 12, no. 1, Jan. 2020, pp. 40-45, https://doi.org/10.25004/IJPSDR.2020.120107.

Issue

Section

Research Article

How to Cite

“Design, Development and Characterization of Curcumin Loaded Albumin Nanoparticles for the Treatment of Parkinson’s Disease”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 12, no. 1, Jan. 2020, pp. 40-45, https://doi.org/10.25004/IJPSDR.2020.120107.